These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 7743308

  • 1. Fluctuations in the secretion of pancreatic enzymes between consecutive doses of octreotide: implications for the management of fistulae.
    Jenkins SA, Nott DM, Baxter JN.
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):255-8. PubMed ID: 7743308
    [Abstract] [Full Text] [Related]

  • 2. Effect of octreotide (SMS 201-995) on meal-stimulated pancreatic secretion in three patients with external pancreatic fistula.
    Gullo L, Biliotti G, Pezzilli R, Di Stefano M, Ancona D.
    Am J Gastroenterol; 1991 Jul; 86(7):892-4. PubMed ID: 2058634
    [Abstract] [Full Text] [Related]

  • 3. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage.
    Nakatsuka A, Yamaguchi K, Chijiiwa K, Tanaka M.
    Int Surg; 2000 Jul; 85(2):124-9. PubMed ID: 11071328
    [Abstract] [Full Text] [Related]

  • 4. [Use of somatostatin analogue for intestinal and pancreatic fistulas].
    Paran H, Neufeld D, Epstein T, Bendahan J, Freund U.
    Harefuah; 1991 Feb 15; 120(4):185-6. PubMed ID: 2066018
    [Abstract] [Full Text] [Related]

  • 5. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.
    Hesse UJ, Meester D, Troisi R, Cathenis K, Lameire N, Hemptinne B.
    Clin Transplant; 2005 Jun 15; 19(3):299-303. PubMed ID: 15877788
    [Abstract] [Full Text] [Related]

  • 6. [Management of postoperative pancreatic fistula resistant to octreotide therapy].
    Dobosz M, Dymecki D, Babicki A, Hać S, Gruca Z, Wajda Z.
    Wiad Lek; 2001 Jun 15; 54(7-8):380-5. PubMed ID: 11641892
    [Abstract] [Full Text] [Related]

  • 7. Short-term administration of SMS 201-995 in the management of an external pancreatic fistula.
    Kwan D, Aufses AH.
    Am J Gastroenterol; 1989 Mar 15; 84(3):326-8. PubMed ID: 2919593
    [Abstract] [Full Text] [Related]

  • 8. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?
    Martineau P, Shwed JA, Denis R.
    Am J Surg; 1996 Oct 15; 172(4):386-95. PubMed ID: 8873537
    [Abstract] [Full Text] [Related]

  • 9. Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands.
    Vanounou T, Pratt WB, Callery MP, Vollmer CM.
    J Am Coll Surg; 2007 Oct 15; 205(4):546-57. PubMed ID: 17903728
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of pancreatic secretion under long-term octreotide treatment in humans.
    Friess H, Bordihn K, Ebert M, Malfertheiner P, Kemmer T, Dennler HJ, Büchler MW.
    Digestion; 1994 Oct 15; 55 Suppl 1():10-5. PubMed ID: 8132133
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of human pancreatic secretion by terbutaline as a potential agent for treating patients with pancreatic fistula.
    Joehl RJ, Nahrwold DL.
    Surg Gynecol Obstet; 1985 Feb 15; 160(2):109-14. PubMed ID: 3969605
    [Abstract] [Full Text] [Related]

  • 12. Failure of somatostatin or an analog to promote closure of end pancreatic fistulae.
    Miller BM, Traverso LW, Freeny PC, Abumrad NN.
    Int J Pancreatol; 1989 Feb 15; 4(1):65-72. PubMed ID: 2466917
    [Abstract] [Full Text] [Related]

  • 13. Role of somatostatin analogues in the management of enterocutaneous fistulae.
    Jamil M, Ahmed U, Sobia H.
    J Coll Physicians Surg Pak; 2004 Apr 15; 14(4):237-40. PubMed ID: 15228830
    [Abstract] [Full Text] [Related]

  • 14. Pancreatic secretion in man: effect of fasting, drugs, pancreatic enzymes, and somatostatin.
    Anand BS, Goodgame R, Graham DY.
    Am J Gastroenterol; 1994 Feb 15; 89(2):267-70. PubMed ID: 7905706
    [Abstract] [Full Text] [Related]

  • 15. Short report: octreotide in the treatment of external pancreatic fistulas.
    Tulassay Z, Flautner L, Vadász A, Fehérvári I.
    Aliment Pharmacol Ther; 1993 Jun 15; 7(3):323-5. PubMed ID: 8364137
    [Abstract] [Full Text] [Related]

  • 16. Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly.
    Turner HE, Thornton-Jones VA, Wass JA.
    Clin Endocrinol (Oxf); 2004 Aug 15; 61(2):224-31. PubMed ID: 15272918
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Collection of pancreatic juice from growing pigs. A comparative study of the pouch method and the catheter method.
    Jensen MS, Gabert VM, Jørgensen H, Engberg RM.
    Int J Pancreatol; 1997 Apr 15; 21(2):173-84. PubMed ID: 9209959
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the effectiveness of octreotide in the conservative treatment of postoperative enterocutaneous fistulas.
    Alivizatos V, Felekis D, Zorbalas A.
    Hepatogastroenterology; 2002 Apr 15; 49(46):1010-2. PubMed ID: 12143189
    [Abstract] [Full Text] [Related]

  • 20. The use of a somatostatin analog in the treatment of an external pancreatic fistula.
    Turner JW.
    Mo Med; 1994 Dec 15; 91(12):737-9. PubMed ID: 7854311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.